FertiScreen: an Online Application to Improve the Quality of Fertility Care
NCT01820039 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152
Last updated 2013-12-16
Summary
Objectives The investigators present an online application to empower and inform patients and improve guideline adherence in unexplained subfertility. Thereby the investigators expect to reduce overtreatment in fertility care with higher quality of care.
Methods The investigators conduct a prospective cohort study including couples with a diagnosis of unexplained subfertility. Couples consulting their general practitioner with an unfulfilled child wish will be offered to use FertiScreen. FertiScreen is an online application, in which patients are asked questions about their fertility problem (ie menstrual cycle, age, duration of child wish and the results of the Chlamydia Trachomatis antibody titre and semen analysis). FertiScreen then uses the validated prediction model of Hunault to calculate couples' chance of natural conception during the next twelve months. In addition, patients can find links to extra information concerning subfertility. Couples can then initiate an online consultation with their general practitioner and a gynaecologist, in order to discuss their results and prognosis. When the calculated prognosis of spontaneous conception within one year is \>30%, tailored expectant management for 6-12 months will be advised, as no benefit can be expected from fertility treatment.
Questionnaires will be sent to patients as well as to their caregivers (general practitioner, gynaecologist). These questionnaires will focus on the use of FertiScreen (System Usability Scale) and the different domains of quality of care (effectiveness, cost-effectiveness, safety, patient-centredness). For the latter, the investigators use the Hospital Anxiety and Depression Scale and the Patient Centredness Questionnaire for Infertility.
In order to be able to draw conclusions, the investigators will conduct a baseline measurement among couples with unexplained subfertility who have been referred to a fertility clinic. Their data will be abstracted from their medical records and they will receive the aforementioned questionnaires as well (except for the System Usability Scale).
The investigators will recruit couples presenting to general practitioners in the Nijmegen area (which for second line treatment consists of one general hospital and one academic hospital). To detect an increase in guideline adherence of the current 60% to 75% with a power of 80% (P\<0,05), the investigators need to include 152 couples in the before as well as in the after measurement.
Conditions
- Unexplained Subfertile Couples With a Good Prognosis.
Interventions
- OTHER
-
FertiScreen
FertiScreen is an online application to assess whether referral is necessary or expectant management is indicated.
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Jan AM Kremer, MD, PhD · IQ Healthcare, UMC St Radboud, Nijmegen, The Netherlands
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 37 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2015-05-31
Countries
- Netherlands
Study Locations
More Related Trials
-
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
NCT00119925 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
NCT00257556 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Fertility Treatments and Fertility Preservation
NCT04602962 ·Status: RECRUITING
-
Retrospective Trial on Low Prognosis Infertile Patients
NCT03290911 ·Status: COMPLETED
-
Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders
NCT06778733 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α
NCT01111084 ·Status: COMPLETED
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Follicle Stimulating Hormone (FSH) Receptor Polymorphisms in In-Vitro Fertilization Cycles.
NCT01002885 ·Status: COMPLETED
-
Intrauterine Insemination Predictor Factors
NCT03836118 ·Status: COMPLETED
-
FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy
NCT02349945 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Reproductive Outcome in Assisted Conception Cycles
NCT03846388 ·Status: COMPLETED ·Phase: NA
-
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
NCT02018159 ·Status: COMPLETED
-
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
NCT01044862 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles
NCT00835744 ·Status: COMPLETED ·Phase: PHASE4
-
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
NCT01206803 ·Status: COMPLETED
-
Predictive Factors of Ovarian Response in Ovulation Induction With Intrauterine Insemination of a Gonal-f Low-dose Regimen
NCT01100346 ·Status: TERMINATED
-
Follicular Challenge Test to Predict Response to GnRH Agonist Triggering
NCT04973969 ·Status: UNKNOWN ·Phase: NA
-
Usability Study of the Pearl Fertility Tracking Device
NCT03924453 ·Status: COMPLETED
-
Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)
NCT00702546 ·Status: COMPLETED
-
Comparison of DuoFertility, LadyComp/BabyComp and Clearblue Monitors
NCT01364935 ·Status: COMPLETED
-
Drop-out of Infertile Couples: a Large Single Center Experience Over 10 Years
NCT06344585 ·Status: COMPLETED
-
An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)
NCT01109654 ·Status: COMPLETED
-
An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques
NCT01149070 ·Status: COMPLETED
-
a Predictive Scheme for Poor Responders in IVF Cycles
NCT02351193 ·Status: COMPLETED
-
Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment
NCT04814940 ·Status: WITHDRAWN